DESFERRIOXAMINE INFUSIONS IN THALASSEMIA MAJOR

被引：0
|
作者：
MATTHEWS, RN
EKERT, H
MCKAY, MRG
机构：
[1] ROYAL CHILDRENS HOSP,DEPT CLIN HAEMATOL & ONCOL,PARKVILLE 3052,VICTORIA,AUSTRALIA
[2] ROYAL CHILDRENS HOSP,DEPT CLIN BIOCHEM,PARKVILLE 3052,VICTORIA,AUSTRALIA
来源：
AUSTRALIAN PAEDIATRIC JOURNAL | 1978年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [11] DESFERRIOXAMINE AND URINARY ZINC EXCRETION IN BETA-THALASSEMIA MAJOR
    UYSAL, Z
    AKAR, N
    KEMAHLI, S
    DINCER, N
    ARCASOY, A
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1993, 10 (03) : 257 - 260
  • [12] Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone
    Telfer, Paul T.
    Warburton, Fiona
    Christou, Soteroula
    Hadjigavriel, Michael
    Sitarou, Maria
    Kolnagou, Anita
    Angastiniotis, Michael
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1777 - 1778
  • [13] IRON ELIMINATION FOLLOWING INTRAVENOUS DESFERRIOXAMINE INFUSION IN PATIENTS WITH THALASSEMIA MAJOR
    DEVIRGILIIS, S
    FRAU, F
    SANNA, G
    CORNACCHIA, G
    TURCO, MP
    ARGIOLU, F
    CAO, A
    EUROPEAN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY, 1985, 2 (01): : 47 - 48
  • [14] PREVENTION OF HEART-DISEASE BY SUBCUTANEOUS DESFERRIOXAMINE IN PATIENTS WITH THALASSEMIA MAJOR
    RICHARDSON, ME
    MATTHEWS, RN
    ALISON, JF
    MENAHEM, S
    MITVALSKY, J
    BYRT, E
    HARPER, RW
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (06): : 656 - 661
  • [15] EFFECT OF SUBCUTANEOUS DESFERRIOXAMINE ON IRON BALANCE IN YOUNG THALASSEMIA MAJOR PATIENTS
    DEVIRGILIIS, S
    COSSU, P
    TOCCAFONDI, C
    SANNA, G
    FRAU, F
    LOBRANO, R
    CORNACCHIA, G
    NUCARO, A
    LOI, A
    BERTOLINO, F
    CAO, A
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1983, 5 (01): : 73 - 77
  • [16] Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study
    Ricchi, Paolo
    Ammirabile, Massimiliano
    Spasiano, Anna
    Costantini, Silvia
    Cinque, Patrizia
    Di Matola, Tiziana
    Pagano, Leonilde
    Prossomariti, Luciano
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (01) : 36 - 42
  • [17] Effect of desferrioxamine on urinary copper and zinc excretion in β-thalassemia major patients
    Akar, N
    Tekin, M
    Uysal, Z
    Uzunali, Ö
    JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 2000, 13 (02): : 195 - 198
  • [18] MANAGEMENT OF THALASSEMIA MAJOR - 15 YEARS EXPERIENCE WITH SUBCUTANEOUS DESFERRIOXAMINE AND HYPERTRANSFUSION THERAPY
    GIARDINA, PJ
    GRADY, RW
    EHLERS, KH
    NEW, MI
    HILGARTNER, MW
    CLINICAL RESEARCH, 1993, 41 (02): : A313 - A313
  • [19] EFFECTS OF 8-YEAR SUBCUTANEOUS DESFERRIOXAMINE ON HEPATITIS STATUS IN THALASSEMIA MAJOR
    ALDOURI, MA
    WONKE, B
    FLYNN, DM
    HOFFBRAND, AV
    SCHEUER, PJ
    KIBBLER, CC
    ALLWOOD, CAM
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 830 - 831
  • [20] HEARING-LOSS ATTRIBUTED TO DESFERRIOXAMINE IN PATIENTS WITH BETA-THALASSEMIA MAJOR
    BARRATT, PS
    TOOGOOD, IRG
    MEDICAL JOURNAL OF AUSTRALIA, 1987, 147 (04) : 177 - 179
12345